Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Drug abuse treatment as AIDS prevention.
  • Published Date:
    Jun 1998
  • Source:
    Public Health Rep. 113(Suppl 1):97-106
  • Language:
    English
Filetype[PDF-3.06 MB]


Details:
  • Alternative Title:
    Public Health Rep
  • Personal Author:
  • Description:
    As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the role playing by substance abuse treatment in the prevention of human immunodeficiency virus (HIV) infection.|The authors review the research literature, examining findings from studies with behavioral and serologic measures on the association among treatment participation, HIV risk reduction, and HIV infection.|Numerous studies have now documented that significantly lower rates of drug use and related risk behaviors are practiced by injecting drug users (IDUs) who are in treatment. Importantly, these behavioral differences, based primarily on self-report, are consistent with studies that have examined HIV seroprevalence and seroincidence among drug users.|The underlying mechanism of action suggested by the collective findings of the available literature is rather simple-- individuals who enter and remain in treatment reduce their drug use, when leads to fewer instances of drug-related risk behavior. This lower rate of exposure results in fewer infections with HIV. The protective effects of treatment, however, can only be achieved when programs are accessible and responsive to the changing needs of drug users. Future research needs to be directed at developing a better understanding of the factors that enhance treatment entry and retention.
  • Subject:
  • Pubmed ID:
    9722815
  • Pubmed Central ID:
    PMCnull
  • Document Type:
    Journal Article
  • Place as Subject:
    United States
  • Collection(s):
    Public Health Reports
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
    1. Public Health Reports ; v. 113, Suppl. 1 : table of contents
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      The National Institute on Drug Abuse (NIDA), in collaboration with the Office of AIDS Research of the National Institutes of Health, invited national and international researchers to the "Research Synthesis Symposium on the Prevention of HIV in Drug ...
      File Type:
      Filetype[PDF - 135.73 KB]
    2. Public Health Reports ; v. 113, Suppl. 1 : cover
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      HIV prevention with drug-using populations : current status and future prospects
      File Type:
      Filetype[PDF - 1.18 MB]
    3. Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers.
      Personal Author:
      Cottler, L B; Compton, W M; Ben Abdallah, A; Cunningham-Williams, R; Abram, F; Fichtenbaum, C; Dotson, W;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):31-41
      Description:
      The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-delivered enhanced intervention to the NIDA standard intervention for reducing human immunodeficienc...
      File Type:
      Filetype[PDF - 7.12 MB]
    4. HIV prevention with drug-using populations--current status and future prospects: introduction and overview.
      Personal Author:
      Needle, R H; Coyle, S L; Normand, J; Lambert, E; Cesari, H;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):4-18
      File Type:
      Filetype[PDF - 3.90 MB]
    5. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.
      Personal Author:
      Latkin, C A
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):151-159
      Description:
      Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunodeficiency virus (HIV) prevention among their contacts within and beyond their sex and drug networks.|...
      File Type:
      Filetype[PDF - 2.59 MB]
    6. Drug abuse treatment success among needle exchange participants.
      Personal Author:
      Brooner, R; Kidorf, M; King, V; Beilenson, P; Svikis, D; Vlahov, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):129-139
      Description:
      Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other desirable outcomes are possible. Referring exchange participants to more comprehensive drug abuse treat...
      File Type:
      Filetype[PDF - 3.39 MB]
    7. Satellite exchange in the Baltimore Needle Exchange Program.
      Personal Author:
      Valente, T W; Foreman, R K; Junge, B; Vlahov, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):90-96
      Description:
      Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or behaviorally from other injecting drug users (IDUs). Our second objective was to determine the degree ...
      File Type:
      Filetype[PDF - 2.32 MB]
    8. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
      Personal Author:
      Singer, M; Baer, H A; Scott, G; Horowitz, S; Weinstein, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):81-89
      Description:
      To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sales of syringes without a physician's prescription. In 1993, the Center for Disease Control and Prev...
      File Type:
      Filetype[PDF - 2.54 MB]
    9. HIV prevention among injecting drug users: responses in developing and transitional countries.
      Personal Author:
      Ball, A L; Rana, S; Dehne, K L;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):170-181
      Description:
      Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. There is evidence that new epidemics are emerging in different regions, including Eastern Europe, La...
      File Type:
      Filetype[PDF - 2.07 MB]
    10. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
      Personal Author:
      Coyle, S L; Needle, R H; Normand, J;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):19-30
      Description:
      Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) interventions for drug users. The authors reviewed the findings related to postintervention behavior changes and...
      File Type:
      Filetype[PDF - 5.34 MB]
    11. The outreach-assisted model of partner notification with IDUs.
      Personal Author:
      Levy, J A; Fox, S E;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):160-169
      Description:
      This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users (IDUs) to inform their partners of shared human immunodeficiency virus (HIV) exposure. The analysis ...
      File Type:
      Filetype[PDF - 2.15 MB]
    12. Public Health Reports ; v. 113, Suppl. 1 : masthead
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      File Type:
      Filetype[PDF - 230.08 KB]
    13. Facilitating treatment entry among out-of-treatment injection drug users.
      Personal Author:
      Booth, R E; Kwiatkowski, C; Iguchi, M Y; Pinto, F; John, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):116-128
      Description:
      High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors has been reported among those who initiate risk reduction. Substance abuse treatment offers the poten...
      File Type:
      Filetype[PDF - 2.90 MB]
    14. Community-based outreach HIV intervention for street-recruited drug users in Madras, India.
      Personal Author:
      Kumar, M S; Mudaliar, S; Daniels, D;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):58-66
      Description:
      Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this chapter is to evaluate the effectiveness of community-based outreach HIV intervention that has been im...
      File Type:
      Filetype[PDF - 3.45 MB]
    15. The role of needle exchange programs in HIV prevention.
      Personal Author:
      Vlahov, D; Junge, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):75-80
      Description:
      Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States, IDUs account for nearly one-third of the cases of acquired immunodeficiency syndrome (AIDS), eithe...
      File Type:
      Filetype[PDF - 1.90 MB]
    16. Bridging the gap between science and practice: insight to researchers from practitioners.
      Personal Author:
      Shriver, M; de Burger, R; Brown, C; Simpson, H L; Meyerson, B;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):189-193
      Description:
      Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the field of human immunodeficiency virus (HIV) prevention among injecting and other drug users. Translat...
      File Type:
      Filetype[PDF - 780.81 KB]
    17. HIV prevention with drug using populations. Current status and future prospects.
      Personal Author:
      Leshner, A I
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):1-3
      File Type:
      Filetype[PDF - 413.01 KB]
    18. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
      Personal Author:
      Heimer, R
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):67-74
      Description:
      This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.|...
      File Type:
      Filetype[PDF - 1.57 MB]
    19. The network approach and interventions to prevent HIV among injection drug users.
      Personal Author:
      Neaigus, A
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):140-150
      Description:
      To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The design and outcomes of selected network-based interventions among IDUs are reviewed using the networ...
      File Type:
      Filetype[PDF - 2.89 MB]
    20. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
      Personal Author:
      Hartel, D M; Schoenbaum, E E;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):107-115
      Description:
      We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection from the earliest days of the HIV epidemic in New York City to the present. The historical context o...
      File Type:
      Filetype[PDF - 3.12 MB]
You May Also Like:
  1. Coming Soon
    Association of rice consumption with risk of cancer incidence in the California Teachers Study
    Personal Author:
    Sanchez, Tiffany R.; Klu, Yaa Asantewaa Kafui; Genkinger, Jeanine M.; Lacey, James V.; Chung, Nadia T.; Navas-Acien, Ana;
    Published Date:
    12/01/2020
    Source:
    Cancer Causes Control. 31(12):1129-1140
    Description:
    Purpose:We evaluated the contribution of rice intake, a source of dietary arsenic, to cancer risk in a population of women with likely low arsenic exposure from drinking water and variable rice intake who participated in the California Teachers Study...
    Public Access
    Available on:
    December 01, 2021
  2. COVID-19 mitigation behaviors by age group — United States, April–June 2020
    Personal Author:
    Hutchins, Helena J.; Wolff, Brent; Leeb, Rebecca; Ko, P Jean Y.; Odom, Erika; Willey, Joe; Friedman, Allison; Bitsko, Rebecca H.;
    Corporate Authors:
    CDC COVID-19 Response Team.. Data Foundation (Washington, DC). National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Human Development and Disability..
    Published Date:
    October 27, 2020
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 27, 2020
    Description:
    What is already known about this topic? Recommended mitigation behaviors to prevent the spread of COVID-19 include wearing masks, hand washing, social distancing, and staying home when ill.What is added by this report? Self-reported engagement in mit...
    File Type:
    Filetype[PDF - 206.47 KB]
  3. COVID-19 outbreak among a university’s men’s and women’s soccer teams — Chicago, Illinois, July–August 2020
    Personal Author:
    Teran, Richard A.; Ghinai, Isaac; Gretsch, Stephanie; Cable, Tracy; Black, Stephanie R.; Green, Stefan J.; Perez, Omar; Chlipala, George E.; Maienschein-Cline, Mark; Kunstman, Kevin J.; Bleasdale, Susan C.; Fricchione, Marielle J.;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service.. Chicago (Ill.). Department of Public Health.. University of Illinois at Chicago..
    Published Date:
    October 27, 2020
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 27, 2020
    Description:
    What is already known about this topic? SARS-CoV-2 transmission occurs in congregate settings, including colleges and universities.What is added by this report? Investigation of 17 COVID-19 cases among a university’s men’s and women’s soccer te...
    File Type:
    Filetype[PDF - 192.87 KB]
  4. Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 — National Immunization Survey-Child, United States, 2017–2019
    Personal Author:
    Hill, Holly A.; Yankey, David; Elam-Evans, Laurie D.; Singleton, James A.; Pingali, S. Cassandra; Santibanez, Tammy A.;
    Published Date:
    October 23 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(42):1505-1511
    Description:
    Immunization has been described as a "global health and development success story," and worldwide is estimated to prevent 2-3 million deaths annually.* In the United States, the Advisory Committee on Immunization Practices (ACIP) currently recommends...
    File Type:
    Filetype[PDF - 201.36 KB]
  5. Risk for In-Hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020
    Personal Author:
    Cates, Jordan; Lucero-Obusan, Cynthia; Dahl, Rebecca M.; Schirmer, Patricia; Garg, Shikha; Oda, Gina; Hall, Aron J.; Langley, Gayle; Havers, Fiona P.; Holodniy, Mark; Cardemil, Cristina V.;
    Published Date:
    October 23 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(42):1528-1534
    Description:
    Coronavirus disease 2019 (COVID-19) is primarily a respiratory illness, although increasing evidence indicates that infection with SARS-CoV-2, the virus that causes COVID-19, can affect multiple organ systems (1). Data that examine all in-hospital co...
    File Type:
    Filetype[PDF - 151.61 KB]